Back to top of page

Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)

Required information for application:

1. Name of the applicant/investigator

2. Affiliation/institution of the applicant

3. Contact information (email address, phone number)

4. Title of the project

5. Summary/abstract of the project

6. Objective(s) of the project

7. Specific aims of the project

8. Rationale for accessing contract research/medical organizations (CROs/CMOs) and subject matter experts (SMEs) within the NINDS Ultra-Rare Gene-based Therapy (URGenT) Network

9. Detailed description of the planned activities, including planning, manufacturing, and limited nonclinical therapeutic development efforts

10. Expected outcomes and potential impact of the project

11. Budget breakdown and justification for the requested resources

12. Timeline for project execution

13. Any additional supporting documents or letters of recommendation (if applicable)

14. Compliance with ethical guidelines and regulatory requirements

15. Previous experience/relevant expertise of the applicant/investigator in gene-based therapy research (if applicable)

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows